|
MechanismPI3K family inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shandong Xuanshuo Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shandong Xuanshuo Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shandong Xuanshuo Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shandong Xuanshuo Pharmaceutical Technology Co., Ltd.